Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Oral Medicine · Oral Leukoplakia

Is Laser Ablation Better Than Surgery for Oral Leukoplakia?

At a Glance

Neither laser ablation nor surgical excision is universally better for oral leukoplakia. Excision provides tissue for pathology and margin assessment, while ablation may preserve healthy tissue but requires an adequate biopsy and does not eliminate recurrence or cancer risk.

When deciding how to treat oral leukoplakia (white patches in the mouth), laser ablation is not universally “better” than surgical excision. Instead, the two approaches offer a significant tradeoff. Excision (cutting the lesion out) provides a tissue specimen that a pathologist can examine under a microscope to confirm the diagnosis and check the surgical margins [1]. Laser ablation (using a laser to vaporize the lesion) preserves more surrounding healthy tissue and can sometimes offer an easier early recovery, but it destroys the tissue, leaving nothing to test for hidden disease [2].

Because neither treatment can guarantee the prevention of oral cancer, the choice depends on your biopsy results, the lesion’s size and location, and whether your clinician needs definitive pathology to rule out severe disease [3].

Before Treatment: The Role of Biopsy

True tissue-destroying ablation should never substitute for an adequate, representative diagnostic biopsy [4]. Oral leukoplakia is a clinical diagnosis, but the tissue itself can range from benign hyperplasia to dysplasia (abnormal cells that can precede cancer) or even hidden cancer [5].

A small (incisional) biopsy might only sample one part of a large or uneven lesion, which can sometimes result in under-grading the severity of the disease [6]. If there is persistent concern for cancer or advanced dysplasia, further biopsy or excision is generally required before considering ablation.

Comparing the Approaches

When reviewing your options, it is important to know that lasers can be used in two different ways: to vaporize tissue (ablation) or to cut tissue like a scalpel (laser excision).

Approach How It Works Provides a Pathology Specimen? Margin Assessment? Key Considerations
Scalpel Excision Cuts out the lesion with a blade. Yes. Yes. Provides substantially more tissue to check for hidden disease, though pathology does not guarantee every abnormal cell is found [1].
Laser Excision Uses a laser as a cutting tool to remove the lesion. Yes. Yes (mostly). Heat from the laser can sometimes cause thermal damage at the edges, which might slightly affect margin assessment [7].
Laser Ablation Vaporizes the lesion with heat (e.g., CO₂ laser). No. No. Tissue is destroyed. Preserves healthy anatomy but prevents final pathology confirmation [2].
Active Surveillance Regular clinical exams; no immediate surgery. No (unless re-biopsied). N/A An option for adequately biopsied, low-risk lesions without dysplasia, avoiding surgery but requiring strict follow-up [8].

The Core Tradeoff: Pathology vs. Tissue Preservation

The most important difference between excision and ablation is whether you receive a final pathology report.

  • Surgical Excision: Removing the tissue allows a pathologist to examine representative sections of the whole lesion. This permits assessment of the surgical margins (the edges of the removed tissue) to see if abnormal cells reach the border [1]. Most importantly, it helps verify if there is any invasive disease or severe dysplasia that was missed by the initial biopsy [9].
  • Laser Ablation: Ablation vaporizes the cells [2]. Because it prevents complete pathology assessment, it may be unsuitable when high-grade dysplasia or invasive disease must be strictly excluded.

Recovery, Pain, and Side Effects

Evidence comparing the recovery of these procedures is mixed and depends heavily on the size and location of the lesion, as well as the specific type of laser used [10][11].

  • Short-Term Recovery: Some studies suggest that laser treatments (particularly diode and CO₂ lasers) may result in less early pain, swelling, and bleeding compared to scalpel surgery [12].
  • Long-Term Healing: By about 5 to 7 weeks post-treatment, healing and pain outcomes between laser and traditional surgery tend to be comparable [12][13].
  • Side Effects: All procedures carry risks, including postoperative pain, delayed healing, and potential functional changes to eating or speaking [14][15]. Laser treatments are often noted for causing minimal scarring, which helps preserve normal mouth anatomy [16].

Recurrence and Cancer Prevention

Many patients assume that surgically removing or lasering off a leukoplakia guarantees it will never turn into oral cancer. Unfortunately, this is a misconception. Reviews of long-term studies conclude that no intervention—whether surgical excision or laser ablation—has been proven to completely prevent long-term recurrence or malignant transformation (turning into cancer) [3][17].

  • Comparative Recurrence: Analyses of randomized trials have found no statistically significant difference in long-term recurrence rates when comparing cold-knife surgery to ablative laser protocols [1].
  • Why Lesions Return: Recurrence can reflect inadequate surgical margins, but it is also driven by the biology of the lesion, the grade of dysplasia, and field cancerization—where the broader area of the mouth has been exposed to risk factors and remains prone to developing new abnormal cells [18][19]. While one specific study found that a 3-millimeter margin improved outcomes with CO₂ laser excision [20], there is no universal margin size that guarantees success for every lesion.
  • The Risk of Recurrence: If a lesion returns, retreatment is often considered. Recurrent leukoplakia is associated with a higher risk of malignant transformation than non-recurrent leukoplakia, emphasizing the need for ongoing vigilance [19].

Long-Term Monitoring

Because neither treatment eliminates the risk of cancer, individualized, long-term (often lifelong) monitoring is essential [21]. Your clinician will determine your follow-up schedule based on your pathology results and risk factors [5].

Between appointments, contact your care team promptly if you notice rapid growth, a new red component or speckled appearance, ulceration (a sore that doesn’t heal), persistent pain, bleeding, or a new lump in the mouth or neck.

Common questions in this guide

Is laser ablation the best treatment for oral leukoplakia?
There is no single best treatment for every oral leukoplakia lesion. Surgical excision removes tissue that can be examined by a pathologist, while laser ablation can preserve more surrounding tissue but destroys the lesion. The choice depends on biopsy results, lesion size and location, and whether hidden severe dysplasia or cancer must be ruled out.
Can laser ablation rule out cancer in oral leukoplakia?
Laser ablation vaporizes the lesion, so it does not provide a final tissue specimen or surgical edges for examination. An adequate, representative biopsy should be completed first; if the biopsy may have missed severe dysplasia or invasive cancer, additional biopsy or excision is generally needed.
What is the difference between laser ablation and laser excision?
Laser ablation uses heat to vaporize the lesion, leaving no tissue for pathology. Laser excision uses the laser like a cutting tool and removes a specimen for testing and usually margin assessment, although heat can affect the specimen edges. These are different procedures even though both use a laser.
Does removing oral leukoplakia prevent it from coming back or becoming cancer?
Neither surgical excision nor laser ablation guarantees that oral leukoplakia will not recur or become cancerous. New or returning lesions can develop because of the lesion’s biology or changes in the surrounding mouth tissue, so long-term monitoring is important.
Is laser treatment less painful than surgery for oral leukoplakia?
Some studies report less early pain, swelling, or bleeding after certain laser procedures, but results vary with the laser, lesion size, and location. By about five to seven weeks, healing and pain may be similar to traditional surgery. Both approaches can cause pain, delayed healing, or temporary changes in eating and speaking.
Can I monitor oral leukoplakia instead of having immediate treatment?
Active surveillance may be reasonable for a properly sampled, low-risk lesion without dysplasia, if your clinician recommends regular examinations. It requires reliable follow-up, and a new or changing lesion may need another biopsy or treatment.

Get notified when new evidence is published on oral mucosa leukoplakia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Surgical protocols for oral leukoplakia and precancerous lesions across three different anatomic sites.

    Pedroso CM, do Santos ES, Alves FA, et al.

    Oral diseases 2025; (31(1)):89-98 doi:10.1111/odi.15098.

    PMID: 39155483
  2. 2

    Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

    Chaturvedi AK, Udaltsova N, Engels EA, et al.

    Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.

    PMID: 31860085
  3. 3

    Randomized Controlled Trials for Oral Leukoplakia.

    Lodolo M, Valor J, Villa A

    Oral diseases 2025; doi:10.1111/odi.15399.

    PMID: 40457716
  4. 4

    Clinical features and presentation of oral potentially malignant disorders.

    Warnakulasuriya S

    Oral surgery, oral medicine, oral pathology and oral radiology 2018; (125(6)):582-590 doi:10.1016/j.oooo.2018.03.011.

    PMID: 29673799
  5. 5

    Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.

    Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S

    Oral diseases 2021; (27(8)):1881-1895 doi:10.1111/odi.13810.

    PMID: 33606345
  6. 6

    Diagnostic discrepancies in the surgical management of oral epithelial dysplasia - an analysis of concordance between incisional biopsy and definitive resection specimens.

    Maloney B, Jung MS, Byrne J, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2026; (142(3)):362-374 doi:10.1016/j.oooo.2026.03.001.

    PMID: 42020233
  7. 7

    Optical Coherence Tomography (OCT) Evaluation of Thermal Tissue Alterations After Diode Laser Excision of Oral Leukoplakia (OL).

    Gambino A, Magliano A, Haddad GE, et al.

    Dentistry journal 2026; (14(3)) doi:10.3390/dj14030168.

    PMID: 41892776
  8. 8

    Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia.

    Bukovszky B, Fodor J, Tóth E, et al.

    Journal of clinical medicine 2023; (12(13)) doi:10.3390/jcm12134255.

    PMID: 37445290
  9. 9

    Interventional laser surgery for oral potentially malignant disorders: a longitudinal patient cohort study.

    Thomson PJ, Goodson ML, Cocks K, Turner JE

    International journal of oral and maxillofacial surgery 2017; (46(3)):337-342 doi:10.1016/j.ijom.2016.11.001.

    PMID: 27866683
  10. 10

    Laser Therapy Versus Conventional Treatments in Oral Leukoplakia: A Systematic Review of Efficacy, Recurrence, and Postoperative Outcomes.

    Dipalma G, Inchingolo AM, Lauria P, et al.

    International journal of dentistry 2026; (2026()):2130179 doi:10.1155/ijod/2130179.

    PMID: 41583116
  11. 11

    The application of a carbon dioxide laser in the treatment of superficial oral mucosal lesions.

    Huang Z, Wang Y, Liang Q, et al.

    The Journal of craniofacial surgery 2015; (26(3)):e277-9 doi:10.1097/SCS.0000000000001285.

    PMID: 25974830
  12. 12

    Clinical Outcomes of Diode Laser Ablation Versus Diode Laser Excision in the Management of Oral Leukoplakia: An Observational Study.

    Dua N, Singh N, Gupta RK, et al.

    Cureus 2026; (18(7)):e113690 doi:10.7759/cureus.113690.

    PMID: 42670369
  13. 13

    Wound healing and pain evaluation following diode laser surgery vs. conventional scalpel surgery in the surgical treatment of oral leukoplakia: a randomized controlled trial.

    de Pauli Paglioni M, Pedroso CM, Faustino ISP, et al.

    Frontiers in oral health 2025; (6()):1568425 doi:10.3389/froh.2025.1568425.

    PMID: 40098816
  14. 14

    Recurrence of premalignant oral cavity and oropharynx lesions after pulsed diode laser treatment.

    Sagalow ES, Kumar AT, Banoub RG, et al.

    American journal of otolaryngology 2022; (43(5)):103556 doi:10.1016/j.amjoto.2022.103556.

    PMID: 35952526
  15. 15

    Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review.

    Luo R, Wang Y, Li R, et al.

    BMC oral health 2024; (24(1)):469 doi:10.1186/s12903-024-04179-9.

    PMID: 38632580
  16. 16

    Prevention of Malignant Transformation of Oral Leukoplakia and Oral Lichen Planus Using Laser: An Observational Study

    Arora KS, Bansal R, Mohapatra S, et al.

    Asian Pacific journal of cancer prevention : APJCP 2018; (19(12)):3635-3641 doi:10.31557/APJCP.2018.19.12.3635.

    PMID: 30583693
  17. 17

    Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.

    de Pauli Paglioni M, Migliorati CA, Schausltz Pereira Faustino I, et al.

    Oral oncology 2020; (109()):104850 doi:10.1016/j.oraloncology.2020.104850.

    PMID: 32540612
  18. 18

    Heterogeneous mechanisms, risk stratification, and translational advances in the malignant transformation of oral potentially malignant disorders to oral squamous cell carcinoma.

    Yu Z, Peng H, Cheng X, et al.

    Frontiers in molecular biosciences 2026; (13()):1948915 doi:10.3389/fmolb.2026.1948915.

    PMID: 42828028
  19. 19

    Recurrence in Oral Leukoplakia: A Systematic Review and Meta-analysis.

    Bhattarai BP, Singh AK, Singh RP, et al.

    Journal of dental research 2024; (103(11)):1066-1075 doi:10.1177/00220345241266519.

    PMID: 39290142
  20. 20

    Evaluation of Different Laser-Supported Surgical Protocols for the Treatment of Oral Leukoplakia: A Long-Term Follow-Up.

    Nammour S, Zeinoun T, Namour A, et al.

    Photomedicine and laser surgery 2017; (35(11)):629-638 doi:10.1089/pho.2016.4256.

    PMID: 28426376
  21. 21

    Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.

    Staines K, Rogers H

    British dental journal 2017; (223(9)):655-661 doi:10.1038/sj.bdj.2017.881.

    PMID: 29097794

This comparison of oral leukoplakia treatments is for informational purposes only and does not constitute medical advice. Your clinician should interpret your biopsy and discuss whether ablation, excision, or surveillance is appropriate for you.